Aktienanalyse wird geladen …
WAT · NYSE · Diagnostics & Research · USA
430,43 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3,17 Mrd. | 642,63 Mio. | 10,76 $ | 59,71 Mio. | 0,1 Mio · 0,2 % | — | 59,3 % | 20,3 % | 9,04 $ | 0,91 $ | — |
| 2024 | 2,96 Mrd. | 637,83 Mio. | 10,71 $ | 59,55 Mio. | 0,1 Mio · 0,2 % | — | 59,4 % | 21,6 % | 10,41 $ | 0,75 $ | — |
| 2023 | 2,96 Mrd. | 642,23 Mio. | 10,84 $ | 59,27 Mio. | 0,1 Mio · 0,1 % | 1,1 Mio · 1,9 % | 59,6 % | 21,7 % | 7,46 $ | 0,62 $ | — |
| 2022 | 2,97 Mrd. | 707,76 Mio. | 11,73 $ | 60,33 Mio. | 0,1 Mio · 0,2 % | 1,8 Mio · 3 % | 58 % | 23,8 % | 7,10 $ | 0,71 $ | — |
| 2021 | 2,79 Mrd. | 692,84 Mio. | 11,17 $ | 62,03 Mio. | 0,1 Mio · 0,1 % | 0,5 Mio · 0,7 % | 58,5 % | 24,9 % | 9,33 $ | 0,48 $ | — |
| 2020 | 2,37 Mrd. | 521,57 Mio. | 8,36 $ | 62,41 Mio. | 0,1 Mio · 0,1 % | 5,8 Mio · 9,4 % | 57,4 % | 22,1 % | 9,90 $ | 0,59 $ | — |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|
| Q3 2026 | 1,65 Mrd. | -136 Mio. | 0,00 $ | — | -8,3 % | — |
| Q2 2026 | 1,27 Mrd. | -72 Mio. | 0,00 $ | — | -5,7 % | — |
| Q4 2025 | 932,36 Mio. | 225,71 Mio. | 3,78 $ | 59,76 Mio. | 24,2 % | 1,69 $ |
| Q3 2025 | 799,89 Mio. | 148,92 Mio. | 2,49 $ | 59,62 Mio. | 18,6 % | — |
| Q3 2025 | 799,89 Mio. | 148,92 Mio. | 2,49 $ | 59,62 Mio. | 18,6 % | — |
| Q2 2025 | 771,33 Mio. | 147,11 Mio. | 2,46 $ | 59,66 Mio. | 19,1 % | — |
| Q2 2025 | 771 Mio. | 147 Mio. | 2,46 $ | — | 19,1 % | — |
| Q1 2025 | 661,71 Mio. | 121,38 Mio. | 2,03 $ | 59,71 Mio. | 18,3 % | — |
Waters Corporation is a global analytical instruments and software company that develops technologies used to identify, separate, and measure chemical compounds in laboratory settings. Its core product portfolio includes liquid chromatography systems, mass spectrometry platforms, thermal analysis instruments, chromatography columns, laboratory informatics software, and related consumables and service offerings. Waters Corporation serves customers across pharmaceuticals, biotechnology, clinical research, food safety, environmental testing, materials science, and academic and government laboratories. Through its Waters and TA segments, the company supports regulated testing, quality control, and research workflows with tools designed for precision analysis and dependable laboratory performance. Headquartered in Milford, Massachusetts, Waters Corporation plays an important role in scientific measurement and analytical workflow automation across life sciences and industrial markets.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest WAT und jede andere Aktie unbegrenzt.